Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the stomach. It is characterized by the presence of malignant small cells.
Biomarker and diagnostic research for gastric small cell neuroendocrine carcinoma has been reported in the published literature.
No clinical trials have been registered for gastric small cell neuroendocrine carcinoma.
163 publications have been identified in PubMed for gastric small cell neuroendocrine carcinoma. Research spans Basic Science / Preclinical (22%), Case Report / Case Series (21%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 36 | 22% |
Data assembled from 2 of 12 sources · Last updated Nov 3, 2026, 11:48 PM UTC
Patient case studies
34 |
21% |
Research summaries | 30 | 18% |
Clinical study results | 24 | 15% |
Testing and diagnosis research | 17 | 10% |
New treatment approaches | 11 | 7% |
Disease patterns and progression | 10 | 6% |
Other research | 1 | 1% |
Aly R (2026). [PMID: 32809473](https://pubmed.ncbi.nlm.nih.gov/32809473/). *Unknown Journal*. [Basic Science / Preclinical]
Sei Y (2026). [PMID: 41903127](https://pubmed.ncbi.nlm.nih.gov/41903127/). *Am J Physiol Gastrointest Liver Physiol*. [Basic Science / Preclinical]
Watanabe H (2026). [PMID: 42098026](https://pubmed.ncbi.nlm.nih.gov/42098026/). *Gan To Kagaku Ryoho*. [Case Report / Case Series]
Arends MJ (2026). [PMID: 41724188](https://pubmed.ncbi.nlm.nih.gov/41724188/). *Histopathology*. [Review / Meta-Analysis]
Uccella S (2026). [PMID: 41273419](https://pubmed.ncbi.nlm.nih.gov/41273419/). *Virchows Archiv : an international journal of pathology*. [Review / Meta-Analysis]
Zhang B (2026). [PMID: 41469155](https://pubmed.ncbi.nlm.nih.gov/41469155/). *J Nucl Med*. [Diagnostic / Biomarker]
Gujarathi R (2026). [PMID: 41968866](https://pubmed.ncbi.nlm.nih.gov/41968866/). *Cancer Med*. [Epidemiology / Natural History]
Inoue S (2026). [PMID: 42084869](https://pubmed.ncbi.nlm.nih.gov/42084869/). *JAMA Netw Open*. [Review / Meta-Analysis]
Walter TP (2026). [PMID: 41774886](https://pubmed.ncbi.nlm.nih.gov/41774886/). *J Clin Oncol*. [Clinical Trial Publication]
Li SC (2026). [PMID: 41809875](https://pubmed.ncbi.nlm.nih.gov/41809875/). *World journal of gastroenterology*. [Epidemiology / Natural History]
AI-curated news mentioning gastric small cell neuroendocrine carcinoma
Updated Oct 8, 2026
A study analyzes the clinicopathological and molecular characteristics of primary small cell neuroendocrine carcinoma of the breast across nine cases. This research contributes to the understanding of this rare breast cancer subtype.
A new study presents a prognostic stratification method for locoregional gastric neuroendocrine carcinoma based on pathological nodal area involvement. This research could enhance treatment planning and patient outcomes in this rare cancer type.
A recent study highlights adolescent-onset primary small cell neuroendocrine carcinoma of the nasal cavity as a rare and aggressive cancer, yet with a favorable outcome. This research contributes to the understanding of this uncommon disease and its clinical implications.